Tag:
Cetrorelix
Latest Headlines
Latest Headlines
AEterna drug fails late-stage trial for enlarged prostate
AEterna Zentaris says that a late-stage study of its lead drug cetrorelix for enlarged prostates--or benign prostatic hyperplasia--didn't reach its primary endpoint. In addition, there were no clear
AEterna Zentaris shares plunge on late-stage trial failure
Shares of AEterna Zentaris went into meltdown mode after the developer announced that a closely watched Phase III trial of the benign prostatic hyperplasia drug cetrorelix had failed to hit its
AEterna forges $165M pact with Sanofi
With initial efficacy data from late-stage studies due in the third quarter, AEterna Zentaris has inked a $165 million licensing deal with Sanofi-aventis for cetrorelix, a treatment for benign
AEterna's CEO, CBO resign
David Mazzo announced that he's resigning from AEterna Zentaris after exactly one year as CEO. Reasons for the move were not disclosed. Board chairman Juergen Ernst will serve as interim President
AEterna gets its ducks in a row
Executives at AEterna Zentaris have taken a good, long look at the company's pipeline and operations and have identified a number of changes that will take place. Cetrorelix, currently in a Phase
